PD Dr. med. Beat Förster

The Association of Ischemia Type and Duration with Acute Kidney Injury after Robot-Assisted Partial Nephrectomy.
Obrecht F, Padevit C, Froelicher G, Rauch S, Randazzo M, Shariat SF, John H, Foerster B.
(2023). Curr Oncol. doi: 10.3390/curroncol30110698.

Extraperitoneal extravesical robot-assisted simple prostatectomy (EE-RASP) with intraprostatic urethral reconstruction.
John, H., Burkhardt, O., Tutal, M., Padevit, C., & Foerster, B.
(2023). Urology Video Journal, 18, doi: 100207/j.urolvj.2023.100207

Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative Study.
Marcq, G., Foerster, B., Abufaraj, M., Matin, S. F., Azizi, M., Gupta, M., . . . Kassouf, W.
(2021). Eur Urol Focus. doi:10.1016/j.euf.2021.03.018

Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study.
Foerster, B., Abufaraj, M., Matin, S. F., Azizi, M., Gupta, M., Li, W. M., . . . Shariat, S. F.
(2021). Eur Urol. doi:10.1016/j.eururo.2021.05.004

 Functional Outcomes after Local Salvage Therapies for Radiation-Recurrent Prostate Cancer Patients: A Systematic Review.
Abufaraj, M., Siyam, A., Ali, M. R., Suarez-Ibarrola, R., Yang, L., Foerster, B., & Shariat, S. F.
(2021). Cancers (Basel), 13(2). doi:10.3390/cancers13020244

Diagnostic Value of (18)F-fluorodeoxyglucose Positron Emission Tomography with Computed Tomography for Lymph Node Staging in Patients with Upper Tract Urothelial Carcinoma.
Voskuilen, C. S., Schweitzer, D., Jensen, J. B., Nielsen, A. M., Joniau, S., Muilwijk, T., . . .Hendricksen, K. (2020). Eur Urol Oncol, 3(1), 73-79. doi:10.1016/j.euo.2019.09.004

Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study.
Soria, F., Moschini, M., D’Andrea, D., Abufaraj, M., Foerster, B., Mathiéu, R., . . . Shariat, S. F.
(2020).  Eur Urol Focus, 6(6), 1233-1239. doi:10.1016/j.euf.2018.11.002

Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma.
Pradere, B., D’Andrea, D., Schuettfort, V. M., Foerster, B., Quhal, F., Mori, K., . . . S, F. S.
(2020). World J Urol. doi:10.1007/s00345-020-03479-3

Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer. Kimura, S., D’Andrea, D., Iwata, T., Foerster, B., Janisch, F., Parizi, M. K., . . . Shariat, S. F.
(2020). World J Urol, 38(10), 2501-2511. doi:10.1007/s00345-019-03038-5

Performance of [(68)Ga] Ga-PSMA 11 PET for detecting prostate cancer in the lymph nodes before salvage lymph node dissection: a systematic review and meta-analysis.
Kimura, S., Abufaraj, M., Janisch, F., Iwata, T., Parizi, M. K., Foerster, B., . . . Shariat, S. F.
(2020). Prostate Cancer Prostatic Dis, 23(1), 1-10. doi:10.1038/s41391-019-0156-z

Efficacy of Preoperative Chemotherapy for High Risk Upper Tract Urothelial Carcinoma.
Foerster, B., Abufaraj, M., Petros, F., Azizi, M., Gupta, M., Schweitzer, D., . . . Shariat, S. F.
(2020). J Urol, 203(6), 1101-1108. doi:10.1097/ju.0000000000000737

The Performance of Tumor Size as Risk Stratification Parameter in Upper Tract Urothelial Carcinoma (UTUC).
Foerster, B., Abufaraj, M., Mari, A., Seisen, T., Bandini, M., Schweitzer, D., . . . Shariat, S. F.
(2020). Clin Genitourin Cancer. doi:10.1016/j.clgc.2020.09.002

Incidence and survival outcomes in patients with upper urinary tract urothelial carcinoma diagnosed with variant histology and treated with nephroureterectomy.
Zamboni, S., Foerster, B., Abufaraj, M., Seisen, T., Roupret, M., Colin, P., . . . Moschini, M.
(2019). BJU Int, 124(5), 738-745. doi:10.1111/bju.14751

Role of serum cholinesterase in patients treated with salvage radical prostatectomy.
Vartolomei, M. D., D’Andrea, D., Chade, D. C., Soria, F., Kimura, S., Foerster, B., . . . Shariat, S.F. (2019). Urol Oncol, 37(2), 123-129. doi:10.1016/j.urolonc.2018.11.013

Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma.
Rieken, M., Boorjian, S. A., Kluth, L. A., Capitanio, U., Briganti, A., Thompson, R. H., . . .Shariat, S. F. (2019). World J Urol, 37(8), 1631-1637. doi:10.1007/s00345-018-2555-5

External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
Moschini, M., Zaffuto, E., Karakiewicz, P. I., Andrea, D. D., Foerster, B., Abufaraj, M., . . . Shariat, S. F. (2019). Eur Urol, 75(2), 319-328. doi:10.1016/j.eururo.2018.09.034

A systematic review and meta-analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimens.
Mari, A., Kimura, S., Foerster, B., Abufaraj, M., D’Andrea, D., Hassler, M., . . . Shariat, S. F.
(2019).  BJU Int, 123(1), 11-21. doi:10.1111/bju.14417

Prognostic Value of Concomitant Carcinoma In Situ in the Radical Cystectomy Specimen: A Systematic Review and Meta-Analysis.
Kimura, S., Mari, A., Foerster, B., Abufaraj, M., Vartolomei, M. D., Stangl-Kremser, J., . . . Shariat, S. F. (2019). J Urol, 201(1), 46-53. doi:10.1016/j.juro.2018.05.162

Comparison of perioperative complications and health-related quality of life between robot-assisted and open radical cystectomy: A systematic review and meta-analysis.
Kimura, S., Iwata, T., Foerster, B., Fossati, N., Briganti, A., Nasu, Y., . . . Shariat, S. F.
(2019). Int J Urol, 26(8), 760-774. doi:10.1111/iju.14005

Prognostic value of modified Glasgow Prognostic Score in non-muscle-invasive bladder cancer. Kimura, S., D, D. A., Soria, F., Foerster, B., Abufaraj, M., Vartolomei, M. D., . . . Shariat, S. F.
(2019). Urol Oncol, 37(3), 179.e119-179.e128. doi:10.1016/j.urolonc.2018.11.005

Oncologic outcomes after robot-assisted versus open radical cystectomy: a systematic review and meta-analysis.
Iwata, T., Kimura, S., Foerster, B., Fossati, N., Briganti, A., Karakiewicz, P. I., . . . Shariat, S. F.
(2019). World J Urol, 37(8), 1557-1570. doi:10.1007/s00345-019-02708-8

Perioperative blood transfusion affects oncologic outcomes after nephrectomy for renal cell carcinoma: A systematic review and meta-analysis.
Iwata, T., Kimura, S., Foerster, B., Abufaraj, M., Karakiewicz, P. I., Preisser, F., . . . Shariat, S. F.
(2019). Urol Oncol, 37(4), 273-281. doi:10.1016/j.urolonc.2019.01.018

Endocavitary treatment for upper tract urothelial carcinoma: A meta-analysis of the current literature.
Foerster, B., D’Andrea, D., Abufaraj, M., Broenimann, S., Karakiewicz, P. I., Rouprêt, M., . . . Soria, F. (2019). Urol Oncol, 37(7), 430-436. doi:10.1016/j.urolonc.2019.02.004

Caveolin-1 Expression in Upper Tract Urothelial Carcinoma.
D’Andrea, D., Moschini, M., Foerster, B., Abufaraj, M., Margulis, V., Karam, J., . . . Shariat, S.F.
(2019). Eur Urol Focus, 5(1), 97-103. doi:10.1016/j.euf.2017.06.011

Optimal Management of Upper Tract Urothelial Carcinoma: an Unmet Need.
Azizi, M., Cheriyan, S. K., Peyton, C. C., Foerster, B., Shariat, S. F., & Spiess, P. E.
(2019). Curr Treat Options Oncol, 20(5), 40. doi:10.1007/s11864-019-0637-2

Micropapillary Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-analysis of Disease Characteristics and Treatment Outcomes.
Abufaraj, M., Foerster, B., Schernhammer, E., Moschini, M., Kimura, S., . . . Shariat, S. F.
(2019). Eur Urol, 75(4), 649-658. doi:10.1016/j.eururo.2018.11.052

Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non-muscle-invasive bladder cancer (NMIBC): A systematic review and meta-analysis.
Vartolomei, M. D., Porav-Hodade, D., Ferro, M., Mathieu, R., Abufaraj, M., Foerster, B., . . .
Shariat, S. F.
(2018). Urol Oncol, 36(9), 389-399. doi:10.1016/j.urolonc.2018.05.014

Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients.
Vartolomei, M. D., Kimura, S., Ferro, M., Vartolomei, L., Foerster, B., Abufaraj, M., & Shariat, S. F.
(2018). World J Urol, 36(7), 1019-1029. doi: 0.1007/s00345-018-2235-5

The impact of moderate wine consumption on the risk of developing prostate cancer.
Vartolomei, M. D., Kimura, S., Ferro, M., Foerster, B., Abufaraj, M., Briganti, A., . . . Shariat, S.F. (2018). Clin Epidemiol, 10, 431-444. doi:10.2147/clep.s163668

Oncologic outcomes after minimally invasive surgery for cT1 renal masses: a comprehensive review.
Vartolomei, M. D., Foerster, B., Kimura, S., Autorino, R., Shariat, S. F., & Seitz, C.
(2018). Curr Opin Urol, 28(2), 132-138. doi:10.1097/mou.0000000000000477

Comparison of the EORTC tables and the EAU categories for risk stratification of patients with nonmuscle-invasive bladder cancer.
Rieken, M., Shariat, S. F., Kluth, L., Crivelli, J. J., Abufaraj, M., Foerster, B., . . . Xylinas, E.
(2018). Urol Oncol, 36(1), 8.e17-18.e24. doi:10.1016/j.urolonc.2017.08.027

Predictors of Cancer-specific Survival After Disease Recurrence in Patients With Renal Cell Carcinoma: The Effect of Time to Recurrence.
Rieken, M., Kluth, L. A., Fajkovic, H., Capitanio, U., Briganti, A., Krabbe, L. M., . . . Shariat, S. F.
(2018). Clin Genitourin Cancer, 16(4), e903-e908. doi:10.1016/j.clgc.2018.03.003

Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.
Özsoy, M., D’Andrea, D., Moschini, M., Foerster, B., Abufaraj, M., Mathieu, R., . . . Shariat, S.F.
(2018). Urol Oncol, 36(4), 158.e151-158.e156. doi:10.1016/j.urolonc.2017.12.003

A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer.
Mari, A., Kimura, S., Foerster, B., Abufaraj, M., D’Andrea, D., Gust, K. M., & Shariat, S. F.
(2018). Urol Oncol, 36(6), 293-305. doi:10.1016/j.urolonc.2018.03.018

Oncologic Effect of Cumulative Smoking Exposure in Patients Treated With Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer.
Mari, A., Abufaraj, M., Foerster, B., Özsoy, M., Briganti, A., Rouprêt, M., . . . Shariat, S. F.
(2018). Clin Genitourin Cancer, 16(3), e619-e627. doi:10.1016/j.clgc.2017.10.015

Prognostic Value of Serum Cholinesterase in Non-muscle-invasive Bladder Cancer.
Kimura, S., Soria, F., D’Andrea, D., Foerster, B., Abufaraj, M., Vartolomei, M. D., . . . Gust, K. M. (2018). Clin Genitourin Cancer, 16(6), e1123-e1132. doi:10.1016/j.clgc.2018.07.002

Association of Smoking Status With Recurrence, Metastasis, and Mortality Among Patients With Localized Prostate Cancer Undergoing Prostatectomy or Radiotherapy: A Systematic Review and Meta-analysis.
Foerster, B., Pozo, C., Abufaraj, M., Mari, A., Kimura, S., D’Andrea, D., . . . Shariat, S. F.
(2018). JAMA Oncol, 4(7), 953-961. doi:10.1001/jamaoncol.2018.1071

Robot-assisted partial nephrectomy: systematic review of functional results.
Foerster, B., Kimura, S., Vartolomei, M. D., Abufaraj, M., Gust, K., Fajkovic, H., . . . Seitz, C.
(2018). Curr Opin Urol, 28(2), 123-131. doi:10.1097/mou.0000000000000482

Accurate prediction of progression to muscle-invasive disease in patients with pT1G3 bladder cancer: A clinical decision-making tool.
D’Andrea, D., Abufaraj, M., Susani, M., Ristl, R., Foerster, B., Kimura, S., . . . Shariat, S. F.
(2018). Urol Oncol, 36(5), 239.e231-239.e237. doi:10.1016/j.urolonc.2018.01.018

Clinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomy.
D’Andrea, D., Soria, F., Abufaraj, M., Gust, K., Foerster, B., Vartolomei, M. D., . . . Shariat, S. F.
(2018). Urol Oncol, 36(12), 528.e527-528.e513. doi:10.1016/j.urolonc.2018.09.015

Progressive tissue biomarker profiling in non-muscle-invasive bladder cancer.
D’Andrea, D., Hassler, M. R., Abufaraj, M., Soria, F., Ertl, I. E., Ilijazi, D., . . . Shariat, S. F
(2018). Expert Rev Anticancer Ther, 18(7), 695-703. doi:10.1080/14737140.2018.1474104

Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review. Cumberbatch, M. G. K., Foerster, B., Catto, J. W. F., Kamat, A. M., Kassouf, W., . . . Gontero, P.
(2018). Eur Urol, 73(6), 925-933. doi:10.1016/j.eururo.2018.02.014

Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder.
Abufaraj, M., Shariat, S. F., Foerster, B., Pozo, C., Moschini, M., D’Andrea, D., . . . Seebacher, V. (2018). World J Urol, 36(2), 231-240. doi:10.1007/s00345-017-2116-3

Preoperative anemia is associated with disease recurrence and progression in patients with non-muscle-invasive bladder cancer.
Soria, F., Moschini, M., Abufaraj, M., Wirth, G. J., Foerster, B., Gust, K. M., . . . Shariat, S. F.
(2017). Urol Oncol, 35(3), 113.e119-113.e114. doi:10.1016/j.urolonc.2016.10.021

Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer.
Soria, F., Lucca, I., Moschini, M., Mathieu, R., Rouprêt, M., Karakiewicz, P. I., . . . Shariat, S. F.
(2017).  Urol Oncol, 35(6), 356-362. doi:10.1016/j.urolonc.2017.02.009

Frequency and Prognostic Value of PTEN Loss in Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.
Rieken, M., Shariat, S. F., Karam, J. A., Foerster, B., Khani, F., Gust, K., . . . Margulis, V.
(2017). J Urol, 198(6), 1269-1277. doi:10.1016/j.juro.2017.06.096

External Validation of the Pathologic Nodal Staging Score for Prostate Cancer: A Populationbased Study.
Rieken, M., Kluth, L. A., Seitz, C., Abufaraj, M., Foerster, B., Mathieu, R., . . . Seebacher, V.
(2017). Clin Genitourin Cancer. doi:10.1016/j.clgc.2017.08.002

Impact of Intra- and Postoperative Blood Transfusion on the Incidence, Timing, and Pattern of Disease Recurrence After Radical Cystectomy.
Moschini, M., Soria, F., Abufaraj, M., Foerster, B., D’Andrea, D., Damiano, R., . . . Shariat, S. F.
(2017). Clin Genitourin Cancer, 15(4), e681-e688. doi:10.1016/j.clgc.2017.01.001

Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients.
Moschini, M., Shariat, S. F., Lucianò, R., D’Andrea, D., Foerster, B., Abufaraj, M., . . . Gallina, A.
(2017). Clin Genitourin Cancer, 15(4), e603-e607. doi:10.1016/j.clgc.2016.12.006

Is transurethral resection alone enough for the diagnosis of histological variants? A singlecenter study.
Moschini, M., Shariat, S. F., Freschi, M., Soria, F., D’Andrea, D., Abufaraj, M., . . . Colombo, R.
(2017). Urol Oncol, 35(8), 528.e521-528.e525. doi:10.1016/j.urolonc.2017.03.024

Predicting local failure after radical cystectomy in patients with bladder cancer: Implications for the selection of candidates at adjuvant radiation therapy.
Moschini, M., Shariat, S. F., Abufaraj, M., Foerster, B., D, D. A., Soria, F., . . . Gallina, A.
(2017). Urol Oncol, 35(12), 672.e671-672.e676. doi:10.1016/j.urolonc.2017.08.013

Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy.
Moschini, M., Foerster, B., Abufaraj, M., Soria, F., Seisen, T., Roupret, M., . . . Shariat, S. F.
(2017). World J Urol, 35(10), 1541-1547. doi:10.1007/s00345-017-2026-4

Genetic determinants for chemo- and radiotherapy resistance in bladder cancer.
Mari, A., D’Andrea, D., Abufaraj, M., Foerster, B., Kimura, S., & Shariat, S. F.
(2017). Transl Androl Urol, 6(6), 1081-1089. doi:10.21037/tau.2017.08.19

Frequency and prognostic significance of incidental prostate cancer at radical cystectomy: Results from an international retrospective study.
Malte, R., Kluth, L. A., Kaushik, D., Boorjian, S. A., Abufaraj, M., Foerster, B., . . . Seebacher, V.
(2017). Eur J Surg Oncol, 43(11), 2193-2199. doi:10.1016/j.ejso.2017.08.013

Predictive and Prognostic Value of Preoperative Thrombocytosis in Upper Tract Urothelial Carcinoma.
Foerster, B., Moschini, M., Abufaraj, M., Soria, F., Gust, K. M., Rouprêt, M., . . . Shariat, S. F.
(2017). Clin Genitourin Cancer, 15(6), e1039-e1045. doi:10.1016/j.clgc.2017.06.003

Prognostic role of N-cadherin expression in patients with non-muscle-invasive bladder cancer. Abufaraj, M., Shariat, S. F., Haitel, A., Moschini, M., Foerster, B., Chłosta, P., . . . Albrecht, W.
(2017).  Urol Oncol, 35(5), 264-271. doi:10.1016/j.urolonc.2017.01.012

Prognostic Role of N-cadherin Expression in Patients With Invasive Bladder Cancer.
Abufaraj, M., Haitel, A., Moschini, M., Gust, K., Foerster, B., Özsoy, M., . . . Shariat, S. F.
(2017). Clin Genitourin Cancer. doi:10.1016/j.clgc.2017.07.001

Preoperative anemia is associated with disease recurrence and progression in patients with non-muscle-invasive bladder cancer.
Soria, F., Moschini, M., Abufaraj, M., Wirth, G. J., Foerster, B., Gust, K. M., . . . Shariat, S. F.
(2016). Urol Oncol. doi:10.1016/j.urolonc.2016.10.021

Das Prostatakarzinom: aktuelle Diagnostik und Therapiestandard.
Brachlow, J., Kalin, M., Randazzo, M., Forster, B., & John, H.
(2016). Praxis (Bern 1994), 105(16), 971-977. doi:10.1024/1661 8157/a002437

Management of muscle invasive, locally advanced and metastatic urothelial carcinoma of the bladder: a literature review with emphasis on the role of surgery.
Abufaraj, M., Gust, K., Moschini, M., Foerster, B., Soria, F., Mathieu, R., & Shariat, S. F.
(2016). Transl Androl Urol, 5(5), 735-744. doi:10.21037/tau.2016.08.23

Establishment of a protocol for large-scale gene expression analyses of laser capture microdissected bladder tissue.
Horstmann, M., Foerster, B., Brader, N., John, H., & Maake, C.
(2012). World J Urol, 30(6), 853-859. doi:10.1007/s00345-012-0881-6